Tridek-One

Tridek-One is a biotech company in Paris, France, founded in 2018. It has 2 recorded funding rounds, most recently a Venture Round in September 2022.

Restoring immune homeostasis

Employees
1–10
Founded
2018
Last Round
Venture RoundSep 2022
Rounds
2

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Tridek-One develops a platform of bispecific antibodies that act on the CD31 inhibitory receptor. The platform is designed to modulate activation through cell-specific ITAM receptors, using antibody-mediated agonism of an inhibitory immune checkpoint. This approach underpins the company's work on targeted modulation of immune activity.

Summary

It lists 1–10 employees. Its most recent funding was a Venture Round in Sep 2022. Investors include AdBio Partners, BB Pureos and Bpifrance.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundSep 2022
EUR 16.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tridek-One on Indexed.vc
<a href="https://indexed.vc/companies/tridek-one"><img src="https://indexed.vc/api/badge/company/tridek-one" alt="Tridek-One on Indexed.vc" width="260" height="76" /></a>